切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2016, Vol. 13 ›› Issue (03) : 185 -190. doi: 10.3877/cma.j.issn.1672-6448.2016.03.005

所属专题: 文献

心血管超声影像学

肥厚型梗阻性心肌病室间隔心肌消融术的疗效及术后左心房容积的变化特点
高一鸣1, 王剑鹏1, 赵星1, 李慧1, 段福建1,(), 乔树宾2, 王浩1   
  1. 1. 100037 北京,北京协和医学院 中国医学科学院 国家心血管病中心 阜外医院超声影像中心
    2. 100037 北京,北京协和医学院 中国医学科学院 国家心血管病中心 阜外医院心内科
  • 收稿日期:2015-10-14 出版日期:2016-03-01
  • 通信作者: 段福建

Effect of septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy and the change of left atrial function after procedure

Yiming Gao1, Jianpeng Wang1, Xing Zhao1, Hui Li1, Fujian Duan1,(), Shubin Qiao2, Hao Wang1   

  1. 1. Department of Echocardiography, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    2. Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
  • Received:2015-10-14 Published:2016-03-01
  • Corresponding author: Fujian Duan
  • About author:
    Corresponding author: Duan Fujian, Email:
引用本文:

高一鸣, 王剑鹏, 赵星, 李慧, 段福建, 乔树宾, 王浩. 肥厚型梗阻性心肌病室间隔心肌消融术的疗效及术后左心房容积的变化特点[J]. 中华医学超声杂志(电子版), 2016, 13(03): 185-190.

Yiming Gao, Jianpeng Wang, Xing Zhao, Hui Li, Fujian Duan, Shubin Qiao, Hao Wang. Effect of septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy and the change of left atrial function after procedure[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2016, 13(03): 185-190.

目的

评价肥厚型梗阻性心肌病(HOCM)患者经皮室间隔心肌消融术(PTSMA)的疗效,并应用三维超声心动图(3DE)探讨术后左心房容积的变化特点。

方法

34例HOCM患者入选此研究。于术前1周、术后1周及术后1年行超声心动图检查。经常规超声获取左心室舒张末期前后径(LVd)、左心房最大前后径(LAd)、左心室射血分数(LVEF)、室间隔基底段舒张末期最大厚度(IVSd)、左心室后壁舒张末期厚度(LVPWd)、左心室流出道压差(LVOT-PG)等,经3DE获取左心房时间-容积曲线,测量左心房最大容积(LAVmax)、左心房最小容积(LAVmin)及左心房收缩前容积(LAVp),计算左心房排空分数(LAEF)、左心房被动排空分数(LAPEF)及左心房主动排空分数(LAAEF)及左心房扩张指数(LAEI),比较术前、术后各参数的变化特点。

结果

与术前相比,术后1周LVOT-PG(54.5±34.5)mmHg(1 mmHg=0.133 kPa)、LVEF(71.4±5.7)%、LAVmax(90.2±36.5)ml、LAVp(73.0±34.0)ml及LAVmin(53.2±28.8)ml均明显减低,差异具有统计学意义(t=4.002、3.234、3.502、3.611、2.253,P值均<0.05);术后1年LVOT-PG(38.3±31.7)mmHg、IVSd(16.7±8.3)mm、LVPWd(11.0±1.9)mm、平均E/e′ 12.0±4.6、LAVmax(80.9±24.8)ml、LAVp(61.3±23.1)ml、LAVmin(42.6±19.5)ml、MI 1.46±1.06均明显减低,差异具有统计学意义(t=5.371、4.165、3.473、3.940、3.655、4.046、4.046、Z=-2.873,P值均<0.01),而LAPEF(25.1±5.1)%升高,差异具有统计学意义(t=-3.270,P<0.01)。与术后1周比较,术后1年LVOT-PG、IVSd、LVPWd、LAVmax、LAVp、LAVmin、MI均明显减低,差异值有统计学意义(t=2.256、5.067、3.137、2.200、2.740、2.016、Z=-2.003,P值均<0.05),而LVd(41.6±4.0)mm、LAEF(48.3±7.9)%及LAPEF升高,差异有统计学意义(t=-2.288、-2.725、-2.907,P值均<0.05)。

结论

HOCM患者PTSMA术后左心室流出道梗阻减轻,左心室充盈压降低,二尖瓣反流改善。3DE用于评估左心房大小较二维超声准确而敏感,HOCM患者PTSMA术后各时相LAV逐渐缩小。

Objective

To evaluate the effect of percutaneous transluminal septal myocardial ablation (PTSMA) in patients with hypertrophic obstructive cardiomyopathy (HOCM) and the change of left atrial volume after PTSMA by three-dimensional echocardiography (3DE).

Methods

Thirty-four patients with HOCM were enrolled in this study. Echocardiography was done at 1 week before PTSMA, 1 week and 1 year after PTSMA. Left ventricular end-diastolic diameter (LVd), 1eft atrial diameter (LAd), interventricular septal thickness (IVSd), 1eft ventricular posterior wall thickness (LVPWd), 1eft ventricular ejection fraction (LVEF) and left ventricular out?ow tract peak gradient (LVOT-PG) etc. were acquired by conventional echocardiography. Time-volume curve of left atrium was acquired by 3DE. Left atrial maximal volume (LAVmax), 1eft atrial minimal volume (LAVmin) and 1eft atrial pre-systolic volume (LAVp) were acquaired. Left atrium emptying fraction (LAEF), left atrium passive emptying fraction (LAPEF), left atrium active emptying fraction (LAAEF) and left atrial expansion index (LAEI) were calculated. Comparative analysis was done between before and after PTSMA.

Results

Compared with pre-procedure, LVOT-PG (54.5±34.5) mmHg (1 mmHg=0.133 kPa), LVEF (71.4±5.7)%, LAVmax (90.2±36.5) ml, LAVp (73.0±34.0) ml and LAVmin (53.2±28.8) ml decreased significantly (t=4.002, 3.234, 3.502, 3.611, 2.253, P<0.05) at 1 week after PTSMA; LVOT-PG (38.3±31.7) mmHg, IVSd (16.7±8.3) mm, LVPWd (11.0±1.9) mm, E/e′ 12.0±4.6, LAVmax (80.9±24.8)ml, LAVp (61.3±23.1) ml, LAVmin (42.6±19.5)ml, MI (1.46±1.06) decreased signi?cantly (t=5.371, 4.165, 3.473, 3.940, 3.655, 4.046, 4.046, z=-2.873, P<0.01), but LAPEF (25.1±5.1)% increased signi?cantly (t=-3.270, P<0.01) at 1 year after PTSMA. Compared with 1 week follow-up, LVOT-PG, IVSd, LVPWd, LAVmax, LAVp, LAVmin, MI decreased significantly (t=2.256, 5.067, 3.137, 2.200, 2.740, 2.016, Z=-2.003, P<0.05), but LVd (41.6±4.0) mm, LAEF (48.3±7.9)% and LAPEF increased signi?cantly (t=-2.288, -2.725, -2.907, P<0.05) at 1 year follow-up.

Conclusions

For the patients with HOCM after PTSMA, left ventricular outflow tract obstruction relieved, left ventricular filling pressure decreased, and mitral regurgitation improved. 3DE is more accurate and sensitive than two-dimensional echocardiography to evaluate left atrial size. For the patients with HOCM after PTSMA, left atrial volume decreased progressively.

表1 肥厚型梗阻性心肌病患者经皮穿刺腔内室间隔心肌消融术前、术后左心房(室)常规参数的比较(±s
图2 肥厚型梗阻性心肌病患者经皮穿刺腔内室间隔心肌消融术后1年左心房时间-容积曲线,各时相LAV较术前减低
表2 肥厚型梗阻性心肌病患者经皮穿刺腔内室间隔心肌消融术前、术后1周左心房3DE参数的比较(±s
表3 肥厚型梗阻性心肌病患者经皮穿刺腔内室间隔心肌消融术前、术后1年左心房3DE参数的比较(±s
表4 肥厚型梗阻性心肌病患者经皮穿刺腔内室间隔心肌消融术后1周、术后1年左心房3DE参数的比较(±s
[1]
Kimmelstiel C, Krishnamurthy B, Weintraub A, 等. 酒精室间隔消融术与肥厚型心肌病 [J] . 中华心血管病杂志, 2009, 37(12): 1074-1077.
[2]
Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons [J] . J Am Coll Cardiol, 2011, 58(25): e212-e260.
[3]
肥厚型梗阻性心肌病室间隔心肌消融术中国专家共识组. 肥厚型梗阻性心肌病室间隔心肌消融术中国专家共识 [J] . 中国心血管病研究, 2012, 10(1): 1-7.
[4]
Bonow RO, Carabello BA, Chatterjee K,et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons [J] . Am Coll Cardiol, 2008, 52(13): e1-142.
[5]
Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction [J] . Circulation, 2006, 114(21): 2232-2239.
[6]
Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy [J] . Lancet, 1995, 346(8969): 211-214.
[7]
Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systemic review of published studies [J] . J Interven Cardiol, 2006, 19(4): 319-327.
[8]
Lyne JC, Kolpatrick T, Duncan A, et al. Long-term follow-up of the first patients to undergo transcatheter alcohol septal ablation [J] . Cardiology, 2010, 116(3): 168-173.
[9]
Leonardi RA, Townsend JC, Patel CA, et a1. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy: outcomes in young, middle-aged, and elderly patients [J] . Catheter Cardiovasc Interv, 2013, 82(5): 838-845.
[10]
Steendijk P, Meliga E, Valgimigli M, et al. Acute effects of alcohol septal ablation on systolic and diastolic left ventricular function in patients with hypertrophic obstructive cardiomyopathy [J] . Heart, 2008, 94(10): 1318–1322.
[11]
Meliga E, Steendijk P, Valgimigli M, et al. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops [J] . Am J Cardiol, 2008, 101(8): 1179-1184.
[12]
Chen YZ, Duan FJ, Yuan JS, et al. Effects of alcohol septal ablation on left ventricular diastolic filling patterns in obstructive hypertrophic cardiomyopathy [J] . Heart Vessels, 2015. [Epub ahead of print].
[13]
张家芬, 段福建, 陈石, 等. 肥厚型梗阻性心肌病室间隔消融术后左室心肌功能改变的临床研究 [J] . 中华超声影像学杂志, 2012, 21(12): 1013-1016.
[14]
Iwataki M, Takeuchi M, Otani K, et al. Measurement of left atrial volume from transthoracic three-dimensional echocardiographic datasets using the biplane Simpson′s technique [J] . J Am Soc Echocardiogr, 2012, 25(12): 1319-1326.
[15]
Eshoo S, Semsarian C, Ross DL, et al. Left atrial phasic volumes are modulated by the type rather than the extent of left ventricular hypertrophy [J] . J Am Soc Echocardiogr, 2010, 23(5): 538-544.
[16]
Finocchiaro G, Haddad F, Pavlovic A, et al. Latent Obstruction and Left Atrial Size Are Predictors of Clinical Deterioration Leading to Septal Reduction in Hypertrophic Cardiomyopathy [J] . J Cardiac Fail, 2014, 20(4): 236-243.
[17]
Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendation for the evaluation of left ventricular diastolic function by echocardiography [J] . J Am Soc Echocardiogr, 2009, 22(2): 107-133.
[18]
Nagueh SF, Lakkis NM, Middleton KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy [J] . Circulation, 1999, 99(2): 254-261.
[19]
Nagueh SF, Lakkis NM, Middleton KJ, et al. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy [J] . J Am Coll Cardiol, 1999, 34(4): 1123-1128.
[1] 张婉微, 秦芸芸, 蔡绮哲, 林明明, 田润雨, 金姗, 吕秀章. 心肌收缩早期延长对非ST段抬高型急性冠脉综合征患者冠状动脉严重狭窄的预测价值[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1016-1022.
[2] 任书堂, 刘晓程, 张亚东, 孙佳英, 陈萍, 周建华, 龙进, 黄云洲. 左心室辅助装置支持下单纯收缩期主动脉瓣反流的超声心动图特征[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1023-1028.
[3] 孙佳英, 黄云洲, 任书堂, 王翠华, 陈新华, 于艾嘉, 陈元禄. 无创心肌做功对左束支传导阻滞患者左心室整体及节段心肌收缩功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(08): 836-843.
[4] 钟露, 曹省, 宋宏宁, 陈金玲, 周青. 超声心动图定量评估二尖瓣反流程度的质量控制[J]. 中华医学超声杂志(电子版), 2023, 20(07): 705-711.
[5] 金姗, 丁雪晏, 蔡绮哲, 李一丹, 赵智玲, 郭兮恒, 吕秀章. 左心室压力-应变环对阻塞型睡眠呼吸暂停综合征患者心肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(06): 575-580.
[6] 李沅芝, 李一丹, 丁雪晏, 郭迪晨, 叶晓光, 孙兰兰, 魏丽群, 朱维维, 王江涛, 吕秀章. 无创左心室压力-应变环评价阵发性心房颤动患者左心室心肌做功的价值[J]. 中华医学超声杂志(电子版), 2022, 19(10): 1071-1076.
[7] 刘婷婷, 丁明岩, 冀威, 郭丽娟, 李颖, 赵含章, 朱芳. 非冠状动脉梗阻性缺血性心脏病女性患者心率储备与微循环功能障碍的相关性研究[J]. 中华医学超声杂志(电子版), 2022, 19(10): 1077-1082.
[8] 张贺彬, 高枫, 郑哲岚, 王晓嫚, 陈丽, 杨寸芯, 胡佩佩. 二维斑点追踪超声心动图对业余马拉松运动员右心室收缩功能的评估[J]. 中华医学超声杂志(电子版), 2022, 19(10): 1091-1097.
[9] 钟春燕, 董虹美, 张晓航, 冉素真. 胎儿永存左上腔静脉合并肺/主动脉和右/左心室比例异常的产前超声诊断及预后分析[J]. 中华医学超声杂志(电子版), 2022, 19(09): 933-940.
[10] 张红梅, 李春梅, 王胰, 张清凤, 丁戈琦, 邓燕, 林薿, 李文华, 尹立雪. 经胸右心声学造影不同右心房增压方式评估卵圆孔未闭隐匿性右向左分流的价值[J]. 中华医学超声杂志(电子版), 2022, 19(06): 508-513.
[11] 杨喆, 尹立雪, 王斯佳, 罗素秋, 赵欣, 周乔, 苏江, 邬锐. 超声血流向量成像对痛风患者左心室能量损耗的初步评价[J]. 中华医学超声杂志(电子版), 2022, 19(06): 527-534.
[12] 陈丽炯, 赵博文, 陈冉, 潘美, 彭晓慧, 楼海亚, 王蓓. 单纯性卵圆孔瓣开放过度与开放受限胎儿的超声心动图评估[J]. 中华医学超声杂志(电子版), 2022, 19(04): 350-356.
[13] 陈樱, 陈艳莉. 高龄孕妇心率变异性原因及围产结局分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 295-301.
[14] 江岚, 梁伟翔, 苏春宏, 苏志源, 刘丹丹, 戴丽, 陈敦金. 超声心动图评估妊娠合并严重心脏病患者剖宫产围术期心容量及功能的变化特征[J]. 中华产科急救电子杂志, 2023, 12(01): 28-35.
[15] 李燕伟, 黄大军, 伍洲, 张嬿, 康彧, 孔令秋. 曲折的右心声学造影一例[J]. 中华心脏与心律电子杂志, 2023, 11(03): 179-181.
阅读次数
全文


摘要